Curcumin co-treatment ameliorates resistance to gefitinib in drug resistant NCI-H1975 lung cancer cells | |
Jin Xin; Wang Jue; Shen Huifen; Ran Ran; Xu Kai; Tong Xiangming; Zhang Weiping; Feng Li | |
2017 | |
卷号 | 37期号:3页码:355-360 |
关键词 | Lung neoplasms Cell line tumor Curcumin Cell proliferation Apoptosis Receptor epidermal growth factor Gefitinib |
ISSN号 | 0255-2922 |
URL标识 | 查看原文 |
收录类别 | SCIE ; CSCD |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6365367 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Jin Xin,Wang Jue,Shen Huifen,et al. Curcumin co-treatment ameliorates resistance to gefitinib in drug resistant NCI-H1975 lung cancer cells[J],2017,37(3):355-360. |
APA | Jin Xin.,Wang Jue.,Shen Huifen.,Ran Ran.,Xu Kai.,...&Feng Li.(2017).Curcumin co-treatment ameliorates resistance to gefitinib in drug resistant NCI-H1975 lung cancer cells.,37(3),355-360. |
MLA | Jin Xin,et al."Curcumin co-treatment ameliorates resistance to gefitinib in drug resistant NCI-H1975 lung cancer cells".37.3(2017):355-360. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论